X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1546) 1546
Newsletter (98) 98
Publication (79) 79
Book Review (14) 14
Book Chapter (3) 3
Magazine Article (3) 3
Trade Publication Article (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lisinopril (1005) 1005
male (764) 764
humans (706) 706
animals (531) 531
angiotensin-converting enzyme inhibitors - pharmacology (516) 516
pharmacology & pharmacy (494) 494
lisinopril - pharmacology (480) 480
female (433) 433
rats (371) 371
hypertension (326) 326
middle aged (324) 324
blood pressure - drug effects (305) 305
hypertension - drug therapy (292) 292
adult (286) 286
angiotensin-converting enzyme inhibitors - therapeutic use (268) 268
aged (243) 243
index medicus (239) 239
lisinopril - therapeutic use (227) 227
captopril (205) 205
enalapril (188) 188
enalapril - analogs & derivatives (164) 164
antihypertensive agents - pharmacology (144) 144
angiotensin (143) 143
hypertension - physiopathology (143) 143
antihypertensive agents - therapeutic use (133) 133
cardiac & cardiovascular systems (132) 132
ace inhibitors (129) 129
rats, wistar (129) 129
blood-pressure (125) 125
angiotensin-converting enzyme inhibitors - administration & dosage (124) 124
enalapril - pharmacology (124) 124
peripheral vascular disease (122) 122
lisinopril - administration & dosage (121) 121
double-blind method (116) 116
dose-response relationship, drug (115) 115
angiotensin-converting enzyme (114) 114
research (113) 113
peptidyl-dipeptidase a - metabolism (105) 105
time factors (102) 102
angiotensin-converting enzyme inhibitors - adverse effects (101) 101
heart rate - drug effects (99) 99
angiotensin-converting enzyme inhibitors (97) 97
captopril - pharmacology (97) 97
enalapril - therapeutic use (96) 96
blood pressure (93) 93
rats, sprague-dawley (93) 93
hemodynamics - drug effects (85) 85
renin-angiotensin system - drug effects (84) 84
enzymes (82) 82
treatment outcome (81) 81
biochemistry & molecular biology (77) 77
heart failure - drug therapy (76) 76
losartan (76) 76
drug therapy (74) 74
drug therapy, combination (74) 74
drugs (73) 73
system (73) 73
dipeptides - pharmacology (72) 72
disease models, animal (72) 72
lisinopril - adverse effects (72) 72
angiotensin receptor antagonists (68) 68
angiotensin-converting enzyme inhibitors - pharmacokinetics (68) 68
dosage and administration (68) 68
expression (68) 68
urology & nephrology (68) 68
antihypertensive agents - administration & dosage (67) 67
rats, inbred shr (66) 66
risk factors (66) 66
kidney - drug effects (64) 64
renin-angiotensin system (63) 63
hydrochlorothiazide (62) 62
mortality (62) 62
medicine & public health (61) 61
pharmacology/toxicology (61) 61
angiotensin converting enzyme (59) 59
drug interactions (59) 59
angiotensin-ii (58) 58
kinetics (58) 58
angiotensin ii (57) 57
physiology (56) 56
lisinopril, adverse reactions - serious (54) 54
pharmacokinetics (54) 54
physiological aspects (54) 54
analysis (53) 53
enalapril - adverse effects (53) 53
pharmacology (53) 53
complications and side effects (52) 52
reports (52) 52
enalapril - administration & dosage (51) 51
losartan - pharmacology (51) 51
bradykinin (50) 50
inhibition (50) 50
antihypertensive agents - adverse effects (49) 49
hypertension - complications (49) 49
aged, 80 and over (48) 48
heart-failure (48) 48
rat (48) 48
renin-angiotensin system - physiology (48) 48
heart (47) 47
heart failure (47) 47
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1596) 1596
Russian (23) 23
French (9) 9
Japanese (6) 6
Portuguese (5) 5
Italian (4) 4
Spanish (3) 3
German (2) 2
Croatian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2009, Volume 329, Issue 3, pp. 928 - 937
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2008, Volume 153, Issue 5, pp. 947 - 955
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 07/2015, Volume 23, Issue 13, pp. 3526 - 3533
Journal Article
Circulation, ISSN 0009-7322, 08/2004, Volume 110, Issue 5, pp. 552 - 557
Background - In hypertensive left ventricular hypertrophy (LVH), myocardial texture is altered by a disproportionate increase in fibrosis, but there is... 
Hypertension | Myocardium | Collagen | Angiotensin | CARDIAC & CARDIOVASCULAR SYSTEMS | PROCOLLAGEN TYPE-I | BACKSCATTER | collagen | RATS | myocardium | TISSUE CHARACTERIZATION | LEFT-VENTRICULAR HYPERTROPHY | COLLAGEN TYPE-I | LISINOPRIL-MEDIATED REGRESSION | ARTERIAL-HYPERTENSION | angiotensin | PERIPHERAL VASCULAR DISEASE | CARBOXY-TERMINAL PROPEPTIDE | HEMATOLOGY | hypertension | HYPERTENSIVE HEART-DISEASE | Antihypertensive Agents - pharmacology | Myocardium - chemistry | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Adrenergic beta-Antagonists - pharmacology | Peptide Fragments - blood | Ultrasonography | Aged, 80 and over | Adult | Female | Adrenergic beta-Antagonists - therapeutic use | Atenolol - pharmacology | Double-Blind Method | Hypertrophy, Left Ventricular - blood | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Losartan - pharmacology | Myocardium - pathology | Treatment Outcome | Antihypertensive Agents - therapeutic use | Collagen - blood | Atenolol - therapeutic use | Fibrosis | Losartan - therapeutic use | Biomarkers | Hypertension - complications | Aged | Hypertrophy, Left Ventricular - diagnostic imaging | Losartan/pharmacology/therapeutic use | Biological Markers | Angiotensin II Type 1 Receptor Blockers/pharmacology/therapeutic use | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/pharmacology/therapeutic use | 80 and over | Myocardium/chemistry/pathology | Adrenergic beta-Antagonists/pharmacology/therapeutic use | MEDICAL AND HEALTH SCIENCES | Collagen/blood | Hypertension/complications/drug therapy | Antihypertensive Agents/pharmacology/therapeutic use | Peptide Fragments/blood | control/ultrasonography | Hypertrophy | Left Ventricular/blood/etiology/prevention
Journal Article
Journal Article
Peptides, ISSN 0196-9781, 2008, Volume 29, Issue 2, pp. 261 - 267
Journal Article
Hypertension, ISSN 0194-911X, 01/1998, Volume 31, Issue 1, pp. 356 - 361
Angiotensin-converting enzyme (ACE) inhibition alone or in combination with the angiotensin type-I receptor (AT(1)) antagonist losartan augments circulating... 
Hypertension | Lisinopril | Angiotensin-(1-7) | Losartan | Neprilysin | Angiotensin-converting enzyme | SHB | NATRIURETIC ACTION | CONVERTING ENZYME | NEUTRAL ENDOPEPTIDASE | RECEPTOR | CONSCIOUS RATS | lisinopril | SPONTANEOUSLY HYPERTENSIVE RATS | PLASMA | neprilysin | NITRIC-OXIDE | angiotensin-(1-7) | PERIPHERAL VASCULAR DISEASE | INHIBITORS | losartan | SHR | hypertension | BRADYKININ | angiotensin-converting enzyme
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2007, Volume 29, Issue 2, pp. 279 - 289
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 02/2008, Volume 35, Issue 2, pp. 159 - 167
SUMMARY 1 The present study was designed to investigate the potential antifibrotic and anti‐oxidant effects of lisinopril, fosinopril and losartan in an... 
liver fibrosis | renin–angiotensin system inhibitors | oxidative stress | Oxidative stress | Renin-angiotensin system inhibitors | Liver fibrosis | TISSUE-INJURY | PHYSIOLOGY | SERUM | CARBON-TETRACHLORIDE TOXICITY | CONVERTING ENZYME-INHIBITORS | COMBINATION | HEPATIC-FIBROSIS | RECEPTOR ANTAGONIST | DAMAGE | FREE-RADICALS | renin-angiotensin system inhibitors | CCL4 | PHARMACOLOGY & PHARMACY | Liver - pathology | Glutathione - metabolism | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Carbon Tetrachloride | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Liver Cirrhosis - chemically induced | Dose-Response Relationship, Drug | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Lisinopril - pharmacology | Liver - drug effects | Lipid Peroxidation - drug effects | Liver Cirrhosis - metabolism | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Disease Models, Animal | Liver Function Tests | Liver Cirrhosis - prevention & control | Hydroxyproline - metabolism | Liver - metabolism | Losartan - pharmacology | Rats | Antioxidants - pharmacology | Antioxidants - therapeutic use | Animals | Fosinopril - pharmacology | Liver Cirrhosis - pathology | Renin-Angiotensin System - drug effects | Oxidative Stress - drug effects | Oxidative Stress, drug effects | Lisinopril, pharmacology | Angiotensin II Type 1 Receptor Blockers, therapeutic use | Antioxidants, pharmacology | Glutathione, metabolism | Angiotensin-Converting Enzyme Inhibitors, pharmacology | Lipid Peroxidation, drug effects | Renin-Angiotensin System, drug effects | Antioxidants, therapeutic use | Angiotensin II Type 1 Receptor Blockers, pharmacology | Liver, pathology | Liver Cirrhosis, metabolism | Liver Cirrhosis, chemically induced | Liver, metabolism | Liver, drug effects | Liver Cirrhosis, pathology | Fosinopril, pharmacology | Hydroxyproline, metabolism | Angiotensin-Converting Enzyme Inhibitors, therapeutic use | Liver Cirrhosis, prevention and control | Losartan, pharmacology | Liver diseases | Carbon tetrachloride | Liver | Lipid peroxidation | Renin-angiotensin system | Glutathione
Journal Article
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, p. 2516
Cancer and stromal cells actively exert physical forces (solid stress) to compress tumour blood vessels, thus reducing vascular perfusion. Tumour interstitial... 
INTERSTITIAL FLUID PRESSURE | BREAST-CANCER | GROWTH-FACTOR-BETA | PANCREATIC STELLATE CELLS | TGF-BETA | AORTIC-ANEURYSM | SOLID STRESS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | GENE-EXPRESSION | II TYPE-2 RECEPTOR
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2015, Volume 80, Issue 4, pp. 662 - 669
Journal Article
Journal Article
Archives of Pharmacal Research, ISSN 0253-6269, 4/2017, Volume 40, Issue 4, pp. 444 - 457
In the present paper 5-[4′-({4-[(4-aryloxy)methyl]-1H-1,2,3-triazol-1-yl}methyl)[1,1′-biphenyl]-2-yl]-1H-tetrazoles (5a–g) and... 
Antifungal activity | Triazole | DTC | Anti-proliferative activity | ACE inhibition | Pharmacy | Tetrazole | Biphenyl | Anti-inflammatory activity | Pharmacology/Toxicology | CHEMISTRY, MEDICINAL | 1,2,3-TRIAZOLE | DENATURATION | II RECEPTOR ANTAGONISTS | DISCOVERY | POTENT | INHIBITION | INFLAMMATION | PHARMACOLOGY & PHARMACY | DERIVATIVES | EXTRACT | Tetrazoles - pharmacology | Antineoplastic Agents - chemical synthesis | Humans | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Antifungal Agents - chemical synthesis | Antifungal Agents - chemistry | Structure-Activity Relationship | Angiotensin-Converting Enzyme Inhibitors - chemical synthesis | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Tetrazoles - chemistry | Inflammation - drug therapy | Drug Design | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Molecular Structure | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Antifungal Agents - pharmacology | Tetrazoles - chemical synthesis | Fungi - drug effects | Antineoplastic Agents - chemistry | Angiotensin-Converting Enzyme Inhibitors - chemistry | Receptor, Angiotensin, Type 1 - agonists | Animals | Cell Line, Tumor | Cell Proliferation - drug effects | Molecular Docking Simulation | Lisinopril | Denaturation | Antifungal agents | Albumin | Drugstores | Cardiac glycosides | Proteins | Cardiotonic agents | Triazoles | Analysis | Angiotensin converting enzyme | Angiotensin
Journal Article
Hypertension, ISSN 0194-911X, 11/2010, Volume 56, Issue 5, pp. 871 - 878
We have shown previously that increased vascular endothelial expression of CYP4A2 leads to 20-hydroxyeicosatetraenoic (20-HETE)-dependent hypertension. The... 
20-HETE | ACE | cytochrome P450 | hypertension | angiotensin II | RENIN-ANGIOTENSIN | NORMAL BLOOD-PRESSURE | ENDOTHELIAL DYSFUNCTION | ARACHIDONIC-ACID | SALT-SENSITIVE RATS | OMEGA-HYDROXYLASE | PERIPHERAL VASCULAR DISEASE | VASCULAR REACTIVITY | EXPRESSION | CYTOCHROME-P-450 | Endothelium, Vascular - cytology | Oligonucleotide Array Sequence Analysis | Blood Pressure - genetics | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Endothelium, Vascular - drug effects | Angiotensin II Type 1 Receptor Blockers - pharmacology | Peptidyl-Dipeptidase A - genetics | Receptor, Angiotensin, Type 1 - genetics | Hydroxyeicosatetraenoic Acids - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Lisinopril - pharmacology | Time Factors | Hydroxyeicosatetraenoic Acids - pharmacology | Mass Spectrometry | Peptidyl-Dipeptidase A - metabolism | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Hypertension - genetics | Angiotensin II - metabolism | Cells, Cultured | Losartan - pharmacology | Rats | Reverse Transcriptase Polymerase Chain Reaction | Lentivirus | Rats, Sprague-Dawley | Blotting, Western | Hypertension - metabolism | Hydroxyeicosatetraenoic Acids - metabolism | Animals | Analysis of Variance | Endothelium, Vascular - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Losartan - therapeutic use | Cytochrome P-450 Enzyme System - genetics | Renin-Angiotensin System - drug effects | Amidines - pharmacology
Journal Article